-
Innovation Ranking
NewInnovation Ranking – Thor Industries Inc
Thor Industries Inc (Thor) manufacturers and selles a range of recreational vehicles (RVs) and related parts and accessories in the US, Canada, and countries in Europe. The company produces equestrian and other specialty towable recreational vehicles, and Class A, Class B and Class C motorhomes. Thor also produces towable recreational vehicles in North America including conventional travel trailers, non-motorized vehicles and fifth wheels. The company offers various towable and motorized recreational vehicles in Europe, which include caravans, campervans, urban vehicles,...
-
Product Insights
Thor Offshore Wind Farm
Thor Offshore Wind Farm is an offshore wind project located in North Sea, Denmark. The project is owned by RWE AG and is developed by Thor Wind Farm IS. The project is currently under construction. Empower your strategies with our Thor Offshore Wind Farm report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and...
-
Company Insights
Innovation and Patenting activity of Thor Industries Inc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Thor Industries Inc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pegenzileukin in Cutaneous Squamous Cell Carcinoma (cSCC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pegenzileukin in Cutaneous Squamous Cell Carcinoma (cSCC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pegenzileukin in Cutaneous Squamous Cell Carcinoma (cSCC) Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pegenzileukin in Oropharyngeal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pegenzileukin in Oropharyngeal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pegenzileukin in Oropharyngeal Cancer Drug Details: SAR-444245 (THOR-707) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pegenzileukin in Colon Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pegenzileukin in Colon Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pegenzileukin in Colon Cancer Drug Details: SAR-444245 (THOR-707) is under development for...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Pegenzileukin in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pegenzileukin in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pegenzileukin in Non-Small Cell Lung Cancer Drug Details: SAR-444245 (THOR-707)...
-
Product Insights
Segilola Project
The Segilola Project is a gold mine in Nigeria. It is currently in operation. Empower your strategies with our Segilola Project report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Gain vital information...
-
Product Insights
Molyhil Project
The Molyhil Project is a molybdenum project in Australia. It is currently at the feasibility stage. Empower your strategies with our Molyhil Project report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Gain...